Susan Kilsby is the Chair of Fortune Brands Home & Security Inc. and is Senior Independent Director and Chair of the Remuneration Committee at Diageo. She is Non-Executive Director of BHP Group plc, at Unilever plc and the UK’s National Health Service (NHS-England). She is also a member of The Takeover Panel in the UK.
Susan previously served as Chairman of Shire plc until its sale in January 2019 to Takeda, and served on the Boards of BBA Aviation, where she was Senior Independent Director and Remuneration Committee Chairman, Goldman Sachs International, Coca-Cola HBC AG, Keurig Green Mountain, where she chaired the Audit Committee, and L’Occitane SA, where she chaired the Remuneration Committee. From 2009 to 2014, Susan was a Senior Advisor at Credit Suisse where she focused on senior-level coverage of global corporations.
Susan joined The First Boston Corp., a predecessor company of Credit Suisse, in 1980, working in the Mergers and Acquisitions Group in New York until 1992. She later moved to London as Head of Credit Suisse’s European Consumer, Retail & Services group in Investment Banking, and from 2002 until 2007 was Head of Mergers & Acquisitions and Strategic Advisory for EMEA and later Chairman, prior to being named a Senior Advisor.
In 2007, Susan was recognised by by both “Forbes” and “Financial News” as one of the Top Ten Women in Finance, and was again recognised by “Financial News” each year from 2008 to 2011. From 2010 to 2013 she was Chairman of the international region of C200, an organisation composed of leading women in business globally, and was a founding member of the Competitor Diversity Forum in London.
Susan is a Senior Visiting Fellow of Cass Business School in London and Chairman of the M&A Research Centre at Cass. She is a Trustee of Wellesley College and member of the Business Leadership Council, serves on the Board of Advisors of the Gordon A. Rich Foundation and the Advisory Board of the Diligent Institute, and acts as a Senior Industry Advisor for Star Mountain Capital.
Mentor suggestions
Dr Göran Ando MD, is the retired Chairman of the Board of Directors of Novo Nordisk A/S. Göran is Chairman of Nouscom, Chairman of Tessa Therapeutics Ltd, Chairman of Eyepoint Pharmaceuticals Inc and the Chairman of Nanexa AB. He is a Director of Paraxel International Corp. Göran also serves as an Advisor to Edbi Pte Ltd, Singapore and is Non-Executive Director of EUSA Pharma (UK) Ltd and Selecta Biosciences Inc.
Chad Holliday recently stepped down as the Chairman of Royal Dutch Shell and serves as the Lead Independent Director at Deere & Company and Hospital Corporation of America (HCA). He was previously CEO and then Chairman of Dupont, Chairman of the Bank of America Corporation, The Business Council, Catalyst, the National Academy of Engineering, the Society of Chemical Industry (American Section) and the World Business Council for Sustainable Development.
Vagn Sørensen is Chairman of Air Canada Inc, Chairman of FLSmidth & Co A/S and Scandlines A/S. Vagn is also a Non-Executive Director on the Board of Royal Caribbean Cruises Limited, CNH Industrial, VFS Global AG and a Senior Advisor to EQT Partners A/S and Morgan Stanley.
Pascal Colombani previously chaired the Supervisory Board of Areva, was Chairman of Valeo SA and was Chairman and Chief Executive Officer of the French Atomic Energy Commission. Pascal is President of TII Strategies SASU, a consulting and investment company, since 2014. He also serves as a member of the EMEA advisory board of JPMorgan Chase, as Senior Advisor of Kearney, a global management consulting firm and as a Senior Advisor of Truffle Capital.